Rawi Hazzan

1.3k total citations
8 papers, 101 citations indexed

About

Rawi Hazzan is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Rawi Hazzan has authored 8 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Hepatology and 2 papers in Oncology. Recurrent topics in Rawi Hazzan's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (2 papers) and Liver Diseases and Immunity (2 papers). Rawi Hazzan is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (2 papers) and Liver Diseases and Immunity (2 papers). Rawi Hazzan collaborates with scholars based in Israel, Australia and Spain. Rawi Hazzan's co-authors include Ran Tur‐Kaspa, Stefan Zeuzem, Xavier Forns, Tarik Asselah, Wenjing Lü, Daniel E. Cohen, David Shaw, Edward Tam, Jordan J. Feld and Tania M. Welzel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Hepatology.

In The Last Decade

Rawi Hazzan

5 papers receiving 98 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rawi Hazzan Israel 4 79 74 27 19 18 8 101
Jianning Jiang China 7 94 1.2× 123 1.7× 12 0.4× 33 1.7× 9 0.5× 27 170
A. Thompson United Kingdom 6 65 0.8× 59 0.8× 25 0.9× 19 1.0× 5 0.3× 25 106
Paolo Strignano Italy 9 74 0.9× 69 0.9× 126 4.7× 17 0.9× 16 0.9× 27 205
Eléonora De Martin Italy 7 140 1.8× 107 1.4× 57 2.1× 6 0.3× 7 0.4× 20 165
Adriana Moţoc Romania 4 54 0.7× 60 0.8× 19 0.7× 11 0.6× 8 0.4× 10 98
Anuhya Gampa United States 4 49 0.6× 67 0.9× 17 0.6× 12 0.6× 3 0.2× 8 113
Nail Özgüneş Türkiye 5 55 0.7× 79 1.1× 6 0.2× 31 1.6× 12 0.7× 8 99
V. de Lédinghen France 7 105 1.3× 109 1.5× 35 1.3× 27 1.4× 3 0.2× 11 175
Aimilia Karampatou Italy 3 115 1.5× 106 1.4× 10 0.4× 10 0.5× 4 0.2× 3 154
Saad Al Kaabi Qatar 6 39 0.5× 39 0.5× 23 0.9× 8 0.4× 19 1.1× 19 79

Countries citing papers authored by Rawi Hazzan

Since Specialization
Citations

This map shows the geographic impact of Rawi Hazzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rawi Hazzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rawi Hazzan more than expected).

Fields of papers citing papers by Rawi Hazzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rawi Hazzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rawi Hazzan. The network helps show where Rawi Hazzan may publish in the future.

Co-authorship network of co-authors of Rawi Hazzan

This figure shows the co-authorship network connecting the top 25 collaborators of Rawi Hazzan. A scholar is included among the top collaborators of Rawi Hazzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rawi Hazzan. Rawi Hazzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
3.
Hazzan, Rawi, et al.. (2024). Suboptimal reliability of FIB‐4 and NAFLD‐fibrosis scores for staging of liver fibrosis in general population. JGH Open. 8(2). e13034–e13034. 2 indexed citations
4.
Kalka, Iris, et al.. (2024). SAT-442 Fibro-Predict risk score for liver cirrhosis from nationwide electronic health records. Journal of Hepatology. 80. S645–S646.
5.
6.
Welzel, Tania M., Tarik Asselah, Emily O. Dumas, et al.. (2017). Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial. ˜The œLancet. Gastroenterology & hepatology. 2(7). 494–500. 33 indexed citations
7.
Shimoni, Zvi, Hanna Bin, Shlomo Bulvik, et al.. (2012). The Clinical Response of West Nile Virus Neuroinvasive Disease to Intravenous Immunoglobulin Therapy. SHILAP Revista de lepidopterología. 2(1). e18–e18. 16 indexed citations
8.
Hazzan, Rawi & Ran Tur‐Kaspa. (2010). Bezafibrate Treatment of Primary Biliary Cirrhosis Following Incomplete Response to Ursodeoxycholic Acid. Journal of Clinical Gastroenterology. 44(5). 371–373. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianning Jiang Breakdown of academic impact, for papers by A. Thompson Breakdown of academic impact, for papers by Paolo Strignano Breakdown of academic impact, for papers by Eléonora De Martin Breakdown of academic impact, for papers by Adriana Moţoc Breakdown of academic impact, for papers by Anuhya Gampa Breakdown of academic impact, for papers by Nail Özgüneş Breakdown of academic impact, for papers by V. de Lédinghen Breakdown of academic impact, for papers by Aimilia Karampatou Breakdown of academic impact, for papers by Saad Al Kaabi
Rankless by CCL
2026